XTNT Stock Analysis: Buy, Sell, or Hold?
XTNT - Xtant Medical Holdings, Inc.
$0.44
0.00 (0.34%)
â˛
5d:
+3.35%
30d:
+5.76%
90d:
-22.07%
WAIT
LOW Confidence
Analysis Updated: Aug 7, 2026 12:00 AM ET
Earnings: Aug 11, 2026
2d
Get Alerted When XTNT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: XTNT is fairly priced but lacks strong directional signals. At 0% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: XTNT is fairly priced but lacks strong directional signals. At 0% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: XTNT is currently trading at $0.44, which is considered slightly high relative to its 30-day fair value range of $0.42 to $0.45. From a valuation perspective, the stock is trading at a discount (Forward PE: -88.8) compared to its historical average (65.2). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, XTNT is in a strong downtrend. Immediate support is located at $0.41, while resistance sits at $0.46.
Market Sentiment: XTNT has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $1.35 (+203.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, XTNT is in a strong downtrend. Immediate support is located at $0.41, while resistance sits at $0.46.
Market Sentiment: XTNT has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $1.35 (+203.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$0.42 -
$0.45
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
81.0%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 203.9% below Wall St target ($1.35)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Composite score 53/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.42 -
$0.45
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$0.41
Resistance Level
$0.46
Current Trend
Strong Downtrend
Technical data as of
Aug 7, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-88.84
Wall Street Target
$1.35
(+203.9%)
Revenue Growth (YoY)
-36.5%
Profit Margin
1.5%
PE vs Historical
-88.8 vs 65.2
CHEAP
Share & Embed Analysis
Last updated: August 08, 2026 5:26 AM ET
Data refreshes hourly during market hours. Next update: 6:26 AM
Data refreshes hourly during market hours. Next update: 6:26 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XTNT showing a specific setup today?
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$64 | 57 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$93 | 53 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 62 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$118 | 51 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$236 | 43 HOLD |
